CCCC
Price
$4.10
Change
-$0.05 (-1.20%)
Updated
Jun 22, 04:59 PM (EDT)
Capitalization
455.54M
51 days until earnings call
Intraday BUY SELL Signals
INTS
Price
$3.97
Change
+$0.05 (+1.28%)
Updated
Jun 22, 04:59 PM (EDT)
Capitalization
10.73M
45 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CCCC vs INTS

CCCC vs INTS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CCCC vs. INTS commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and INTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (CCCC: $4.12 vs. INTS: $3.92)
Brand notoriety: CCCC and INTS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 113% vs. INTS: 144%
Market capitalization -- CCCC: $455.54M vs. INTS: $10.73M
CCCC [@Biotechnology] is valued at $455.54M. INTS’s [@Biotechnology] market capitalization is $10.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $1.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileINTS’s FA Score has 1 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • INTS’s FA Score: 1 green, 4 red.
According to our system of comparison, CCCC is a better buy in the long-term than INTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 3 TA indicator(s) are bullish while INTS’s TA Score has 4 bullish TA indicator(s).

  • CCCC’s TA Score: 3 bullish, 5 bearish.
  • INTS’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, INTS is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а +7.85% price change this week, while INTS (@Biotechnology) price change was +6.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.46%. For the same industry, the average monthly price growth was +1.63%, and the average quarterly price growth was +2204.18%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 12, 2026.

INTS is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+4.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CCCC($456M) has a higher market cap than INTS($10.7M). CCCC YTD gains are higher at: 115.707 vs. INTS (-61.775). INTS has higher annual earnings (EBITDA): -11.1M vs. CCCC (-101.2M). CCCC has more cash in the bank: 236M vs. INTS (10.2M). INTS has less debt than CCCC: INTS (102K) vs CCCC (58.4M). CCCC has higher revenues than INTS: CCCC (34.9M) vs INTS (0).
CCCCINTSCCCC / INTS
Capitalization456M10.7M4,262%
EBITDA-101.2M-11.1M911%
Gain YTD115.707-61.775-187%
P/E RatioN/AN/A-
Revenue34.9M0-
Total Cash236M10.2M2,314%
Total Debt58.4M102K57,255%
TECHNICAL ANALYSIS
Technical Analysis
CCCCINTS
RSI
ODDS (%)
Bearish Trend 5 days ago
83%
Bullish Trend 5 days ago
59%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
66%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
81%
Aroon
ODDS (%)
Bullish Trend 5 days ago
79%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signal:
Gain/Loss:
INTS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RYAAY61.240.60
+0.99%
Ryanair Holdings plc
FLX2.190.02
+0.92%
BingEx Ltd.
SFHG2.460.01
+0.41%
Samfine Creation Holdings Group Ltd
PHI17.460.03
+0.17%
PLDT
AMPH18.81-0.60
-3.09%
Amphastar Pharmaceuticals

INTS and

Correlation & Price change

A.I.dvisor tells us that INTS and ACAD have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INTS and ACAD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTS
1D Price
Change %
INTS100%
+6.67%
ACAD - INTS
28%
Poorly correlated
+0.09%
INSM - INTS
27%
Poorly correlated
-2.69%
IMVT - INTS
27%
Poorly correlated
+1.82%
CCCC - INTS
27%
Poorly correlated
+5.87%
ADXN - INTS
26%
Poorly correlated
-0.16%
More